These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects. Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341 [TBL] [Abstract][Full Text] [Related]
24. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction. Sörensen NA; Nikorowitsch J; Neumann JT; Rübsamen N; Goßling A; Hartikainen TS; Blankenberg S; Westermann D; Zeller T; Karakas M Clin Res Cardiol; 2019 Dec; 108(12):1386-1393. PubMed ID: 30989318 [TBL] [Abstract][Full Text] [Related]
25. High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. Samman Tahhan A; Sandesara P; Hayek SS; Hammadah M; Alkhoder A; Kelli HM; Topel M; O'Neal WT; Ghasemzadeh N; Ko YA; Gafeer MM; Abdelhadi N; Choudhary F; Patel K; Beshiri A; Murtagh G; Kim J; Wilson P; Shaw L; Vaccarino V; Epstein SE; Sperling L; Quyyumi AA J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29467150 [TBL] [Abstract][Full Text] [Related]
26. Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients. Huang Y; Zhou H; Wu Y; Yang Y; Li W; Lu J; Hu Y Dis Markers; 2017; 2017():4719403. PubMed ID: 29109596 [TBL] [Abstract][Full Text] [Related]